← Leaderboards
Mark L Lang
Dartmouth College
$8,144,336
Attributed
$8,144,336
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,858,470 · 14
By mechanism
P20$10,053,558 · 7
U19$5,560,057 · 3
R01$3,434,162 · 2
R21$407,000 · 1
R56$403,693 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- William R Green$40,677,734
- Ronald K Taylor$23,036,656
- Claudia V Jakubzick$11,160,006
- Steven Fiering$14,075,746
- Ian Baker$14,474,370
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseResponsePathogenVaccinesB-LymphocytesUnited States National Institutes Of HealthMemory B-LymphocyteCellsClostridium DifficileProgramsLifeAntigensImmunizationHumoral ImmunitiesGenerationsAntibodiesResearch PersonnelIn VivoPlasma CellsFundingInstitutionMediatingOklahomaAffect
Grant awards (32)
Oklahoma IDeA Network of Biomedical Research Excellence$4,207,418
P20 · FY2025 · GM · contact PI
Advancing a second generation C. difficile vaccine$1,315,168
U19 · FY2025 · AI · contact PI
Developmental Research Project Program$1,061,945
P20 · FY2025 · GM · contact PI
Functions of human C. difficile-specific memory B cell-derived monoclonal antibodies$459,400
U19 · FY2025 · AI · contact PI
Oklahoma C. difficile U19 Administrative Core$83,163
U19 · FY2025 · AI · contact PI
Advancing a second generation C. difficile vaccine$1,315,168
U19 · FY2024 · AI · contact PI
Functions of human C. difficile-specific memory B cell-derived monoclonal antibodies$429,723
U19 · FY2024 · AI · contact PI
Oklahoma C. difficile U19 Administrative Core$82,111
U19 · FY2024 · AI · contact PI
Oklahoma IDeA Network of Biomedical Research Excellence$3,561,212
P20 · FY2023 · GM · contact PI
Advancing a second generation C. difficile vaccine$1,315,168
U19 · FY2023 · AI · contact PI
Functions of human C. difficile-specific memory B cell-derived monoclonal antibodies$448,481
U19 · FY2023 · AI · contact PI
Oklahoma C. difficile U19 Administrative Core$111,675
U19 · FY2023 · AI · contact PI
Activation of semi-invariant and diverse NKT cells with an adjuvant combination$367,120
R01 · FY2022 · AI · contact PI
Activation of semi-invariant and diverse NKT cells with an adjuvant combination$367,120
R01 · FY2021 · AI · contact PI
Activation of semi-invariant and diverse NKT cells with an adjuvant combination$367,120
R01 · FY2020 · AI · contact PI
Activation of semi-invariant and diverse NKT cells with an adjuvant combination$367,120
R01 · FY2019 · AI · contact PI
Activation of semi-invariant and diverse NKT cells with an adjuvant combination$367,120
R01 · FY2018 · AI · contact PI
Re-directing B cell responses to carbohydrate antigens$185,000
R21 · FY2017 · AI · contact PI
Re-directing B cell responses to carbohydrate antigens$222,000
R21 · FY2016 · AI · contact PI
Regulation of humoral immunity by NKT cells$403,693
R56 · FY2014 · AI · contact PI
Regulation of humoral immunity by NKT cells$302,320
R01 · FY2013 · AI · contact PI
Regulation of humoral immunity by NKT cells$321,616
R01 · FY2012 · AI · contact PI
Regulation of humoral immunity by NKT cells$321,616
R01 · FY2011 · AI · contact PI
Regulation of humoral immunity by NKT cells$324,864
R01 · FY2010 · AI · contact PI
Regulation of humoral immunity by NKT cells$328,146
R01 · FY2009 · AI · contact PI
ENHANCEMENT OF HUMORAL IMMUNE RESPONSES BY CD1D-RESTRICTED NKT CELLS$60,008
P20 · FY2009 · RR · contact PI
ENHANCEMENT OF HUMORAL IMMUNE RESPONSES BY CD1D-RESTRICTED NKT CELLS$63,469
P20 · FY2008 · RR · contact PI
ENHANCEMENT OF HUMORAL IMMUNE RESPONSES BY CD1D-RESTRICTED NKT CELLS$226,232
P20 · FY2007 · RR · contact PI
ENHANCEMENT OF HUMORAL IMMUNE RESPONSES BY NKT CELLS$27,426
P20 · FY2007 · RR · contact PI
COBRE: DMS: CD1 ACQUISITION OF BCR & FC RECEPTOR TARGETED LIGAND$270,995
P20 · FY2006 · RR · contact PI
COBRE: DMS: CD1 ACQUISITION OF BCR &FC RECEPTOR TARGETED LIGAND$284,202
P20 · FY2005 · RR
COBRE: DMS: CD1 ACQUISITION OF BCR &FC RECEPTOR TARGETED LIGAND$290,651
P20 · FY2004 · RR